As the number one in the diagnostics industry, our pioneering innovations set the standards for the entire industry. Our aim is to make things simpler and more convenient for those treating sick people, and for those being treated. Some diseases, such as malaria, stroke or diabetes, are as old as mankind. Others, such as AIDS or SARS, are more recent challenges. Therefore, we continually search for newer ways to monitor the therapies that make them more manageable - to help people live better lives. At Roche Diagnostics, around 19,000 people work on the broadest product range in the diagno.... Read more

The BenchMark ULTRA system is Roche Tissue Diagnostics’ most innovative, fully...

KAPA HiFi HotStart DNA Polymerase is a novel B-family DNA polymerase, engineered to ...

Easy operation After placing a Combur-Test ® strip on the strip tray and pre...

VENTANA PD-L1 (SP142) Assay is intended for the immunohistochemical assessment of th...

A web-based oncology care team workflow tool that presents patient data in a dashboa...

As the number one in the diagnostics industry, our pioneering innovations set the standards for the entire industry.

Our aim is to make things simpler and more convenient for those treating sick people, and for those being treated. Some diseases, such as malaria, stroke or diabetes, are as old as mankind. Others, such as AIDS or SARS, are more recent challenges. Therefore, we continually search for newer ways to monitor the therapies that make them more manageable - to help people live better lives.

At Roche Diagnostics, around 19,000 people work on the broadest product range in the diagnostics industry and we are always conscious of the special responsibilities our work carries with it: responsibilities towards society, the healthcare community, our people and our shareholders, but most importantly towards all patients, or those who may become patients - lastly towards each and every one of us.

Roche Diagnostics is a division of F. Hoffmann-La Roche Ltd, Basel, Switzerland.